Effect of a Novel Prolyl Endopeptidase Inhibitor, JTP-4819, on Neuropeptide Metabolism in the Rat Brain

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1996 Feb 1

PMID 8692293

Citations 8

Authors

K Toide

T Fujiwara

Y Iwamoto

M Shinoda

K Okamiya

T Kato

Affiliations

Soon will be listed here.

Abstract

The effect of a novel prolyl endopeptidase (PEP) inhibitor, (S)-2-[[(S)-2-(hydroxyacetyl)-1-pyrrolidinyl] carbonyl]-N-(phenylmethyl)-1-pyrrolidine-carboxamide (JTP-4819), on neuropeptide metabolism was investigated in the rat brain. JTP-4819 exhibited a strong in vitro inhibitory effect on cortical and hippocampal PEP activity, with the IC50 values being approximately 0.58 +/- 0.02 and 0.61 +/- 0.06 nM, respectively. JTP-4819 also inhibited the in vitro degradation of substance P (SP), arginine-vasopressin (AVP), and thyrotropin-releasing hormone (TRH) by rat brain supernatants, with the IC50 values being respectively 3.4, 2.1, and 1.4 nM in the cerebral cortex and 3.3, 2.8, and 1.9 nM in the hippocampus. Oral administration of JTP-4819 at doses of 1 and 3 mg/kg increased SP-like immunoreactivity (LI) and AVP-LI in the cerebral cortex. JTP-4819 also increased hippocampal SP-LI and AVP-LI at doses of 1 and 3 mg/kg, as well as hippocampal TRH-LI at a dose of 3 mg/kg. These findings suggest that JTP-4819 inhibited the degradation of SP, AVP, and TRH in the rat brain secondary to the inhibition of PEP, and thus increased cortical and hippocampal SP-LI and AVP-LI as well as hippocampal TRH-LI.

Citing Articles

The pharmacological landscape and therapeutic potential of serine hydrolases.

Bachovchin D, Cravatt B Nat Rev Drug Discov. 2012; 11(1):52-68.

PMID: 22212679 PMC: 3665514. DOI: 10.1038/nrd3620.

Structural analysis of prolyl oligopeptidases using molecular docking and dynamics: insights into conformational changes and ligand binding.

Kaushik S, Sowdhamini R PLoS One. 2011; 6(11):e26251.

PMID: 22132071 PMC: 3223163. DOI: 10.1371/journal.pone.0026251.

The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Long J, Cravatt B Chem Rev. 2011; 111(10):6022-63.

PMID: 21696217 PMC: 3192302. DOI: 10.1021/cr200075y.

Activity-based probes for monitoring postproline protease activity.

Sabido E, Tarrago T, Niessen S, Cravatt B, Giralt E Chembiochem. 2009; 10(14):2361-6.

PMID: 19688784 PMC: 2847404. DOI: 10.1002/cbic.200900244.

Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.

Myohanen T, Garcia-Horsman J, Tenorio-Laranga J, Mannisto P J Histochem Cytochem. 2009; 57(9):831-48.

PMID: 19687473 PMC: 2728128. DOI: 10.1369/jhc.2009.953711.

References

Coyle J, Price D, DeLong M . Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 1983; 219(4589):1184-90. DOI: 10.1126/science.6338589. View

Yoshimoto T, Ogita K, Walter R, Koida M, Tsuru D . Post-proline cleaving enzyme. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man. Biochim Biophys Acta. 1979; 569(2):184-92. DOI: 10.1016/0005-2744(79)90053-6. View

Lippa A, Pelham R, Beer B, Critchett D, Dean R, Bartus R . Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging. 1980; 1(1):13-9. DOI: 10.1016/0197-4580(80)90019-6. View

Dresdner K, Barker L, Orlowski M, Wilk S . Subcellular distribution of prolyl endopeptidase and cation-sensitive neutral endopeptidase in rabbit brain. J Neurochem. 1982; 38(4):1151-4. DOI: 10.1111/j.1471-4159.1982.tb05362.x. View

Perry E . The cholinergic hypothesis--ten years on. Br Med Bull. 1986; 42(1):63-9. DOI: 10.1093/oxfordjournals.bmb.a072100. View

Faden A, Salzman S . Pharmacological strategies in CNS trauma. Trends Pharmacol Sci. 1992; 13(1):29-35. DOI: 10.1016/0165-6147(92)90013-v. View

Wilk S . Prolyl endopeptidase. Life Sci. 1983; 33(22):2149-57. DOI: 10.1016/0024-3205(83)90285-0. View

Koida M, Walter R . Post-proline cleaving enzyme. Purification of this endopeptidase by affinity chromatography. J Biol Chem. 1976; 251(23):7593-9. View

Husain M, Nemeroff C . Neuropeptides and Alzheimer's disease. J Am Geriatr Soc. 1990; 38(8):918-25. DOI: 10.1111/j.1532-5415.1990.tb05710.x. View

10.

Yoshimoto T . [Proline specific peptidases and their specific inhibitors]. Yakugaku Zasshi. 1991; 111(7):345-58. DOI: 10.1248/yakushi1947.111.7_345. View

11.

Taira K, Kaneto H . [Experimental models for studying the avoidance response in mice and the anti-amnesic effect of prolyl endopeptidase inhibitors]. Nihon Yakurigaku Zasshi. 1987; 89(5):243-52. View

12.

Walter R, Shlank H, Glass J, SCHWARTZ I, Kerenyi T . Leucylglycinamide released from oxytocin by human uterine enzyme. Science. 1971; 173(3999):827-9. DOI: 10.1126/science.173.3999.827. View

13.

Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T . Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease. Experientia. 1990; 46(1):94-7. DOI: 10.1007/BF01955428. View

14.

Beal M, Mazurek M . Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology. 1987; 37(7):1205-9. DOI: 10.1212/wnl.37.7.1205. View

15.

OLeary R, OConnor B . Identification and localisation of a synaptosomal membrane prolyl endopeptidase from bovine brain. Eur J Biochem. 1995; 227(1-2):277-83. DOI: 10.1111/j.1432-1033.1995.tb20385.x. View

16.

Taylor W, Dixon J . Catabolism of neuropeptides by a brain proline endopeptidase. Biochem Biophys Res Commun. 1980; 94(1):9-15. DOI: 10.1016/s0006-291x(80)80179-3. View

17.

Suzuki H, Yoshioka K, Yanagisawa M, Urayama O, Kurihara T, Hosoki R . Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord. Br J Pharmacol. 1994; 113(1):310-6. PMC: 1510033. DOI: 10.1111/j.1476-5381.1994.tb16210.x. View

18.

Bartus R, Dean 3rd R, Beer B, Lippa A . The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982; 217(4558):408-14. DOI: 10.1126/science.7046051. View

19.

Toide K, Okamiya K, Iwamoto Y, Kato T . Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J Neurochem. 1995; 65(1):234-40. DOI: 10.1046/j.1471-4159.1995.65010234.x. View

20.

Biggins J, Perry E, McDermott J, Smith A, Perry R, Edwardson J . Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. J Neurol Sci. 1983; 58(1):117-22. DOI: 10.1016/0022-510x(83)90114-4. View